Factor VIII gene and hemophilia A.

[1]  S. Antonarakis,et al.  Haemophilia A resulting from de novo insertion of L1 sequences represents a novel mechanism for mutation in man , 1988, Nature.

[2]  G. Barbujani,et al.  Hemophilia A: carrier detection and prenatal diagnosis by DNA analysis. , 1987, Blood.

[3]  B. Levinson,et al.  A novel missense mutation in the factor VIII gene identified by analysis of amplified hemophilia DNA sequences. , 1987, Nucleic acids research.

[4]  C. Mazurier,et al.  Evidence that NH2-terminal but not COOH-terminal moiety of plasma von Willebrand factor binds to factor VIII. , 1987, Thrombosis Research.

[5]  J. Gitschier,et al.  Genetic mapping and diagnosis of haemophilia A achieved through a BclI polymorphism in the factor VIII gene , 1985, Nature.

[6]  C. Kasper,et al.  Response of patients with mild and moderate hemophilia A and von Willebrand's disease to treatment with desmopressin. , 1985, Annals of Internal Medicine.

[7]  C. Fulcher,et al.  Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[8]  S. Rapaport,et al.  The importance of activation of antihemophilic globulin and proaccelerin by traces of thrombin in the generation of intrinsic prothrombinase activity. , 1963, Blood.

[9]  P. Lollar,et al.  Stoichiometry of the porcine factor VIII-von Willebrand factor association. , 1987, The Journal of biological chemistry.

[10]  R. Heilig,et al.  Genetic screening for hemophilia A (classic hemophilia) with a polymorphic DNA probe. , 1985, The New England journal of medicine.

[11]  A. Dorner,et al.  Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. , 1988, The Journal of biological chemistry.

[12]  J. Griffin,et al.  Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V. , 1984, Blood.

[13]  W. Kane,et al.  Cloning of a cDNA coding for human factor V, a blood coagulation factor homologous to factor VIII and ceruloplasmin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  E. Chen,et al.  Detection and sequence of mutations in the factor VIII gene of haemophiliacs          , 1985, Nature.

[15]  G. Vehar,et al.  Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. , 1986, Biochemistry.

[16]  J. Gitschier,et al.  An improved method for prenatal diagnosis of genetic diseases by analysis of amplified DNA sequences. Application to hemophilia A. , 1987, The New England journal of medicine.

[17]  R. Kaufman,et al.  A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[18]  C. Wolfrom,et al.  Factor VIII Procoagulant Antigen in Human Tissues , 1988, Thrombosis and Haemostasis.

[19]  P. Mannucci,et al.  Carrier detection in hemophilia A: a cooperative international study. I. The carrier phenotype. , 1986, Blood.

[20]  H. Reisner,et al.  Factor VIII coagulant antigen in hemophilic plasma: a comparison of five alloantibodies. , 1980, Blood.

[21]  P. Mannucci,et al.  1-DEAMINO-8-D-ARGININE VASOPRESSIN: A NEW PHARMACOLOGICAL APPROACH TO THE MANAGEMENT OF HAEMOPHILIA AND VON WILLEBRAND'S DISEASE , 1977, The Lancet.

[22]  L. Rydén,et al.  Reinvestigation of some physicochemical and chemical properties of human ceruloplasmin (ferroxidase). , 1976, Biochemistry.

[23]  S. Antonarakis.  Hemophilia A persistence and gene mutational vulnerability. , 1987, Hospital practice.

[24]  M. Griffith,et al.  Measurement of human factor IXa activity in an isolated factor X activation system. , 1982, Thrombosis research.

[25]  L. Hoyer,et al.  The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation. , 1981, The Journal of laboratory and clinical medicine.

[26]  S. Antonarakis,et al.  Hemophilia A. Detection of molecular defects and of carriers by DNA analysis. , 1985, The New England journal of medicine.

[27]  K. Mann,et al.  Internal duplication and sequence homology in factors V and VIII. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W. Wood,et al.  Identification of a missense mutation in the factor VIII gene of a mild hemophiliac. , 1986, Science.

[29]  R. Kaufman,et al.  Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII). , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[30]  K. Titani,et al.  A major factor VIII binding domain resides within the amino-terminal 272 amino acid residues of von Willebrand factor. , 1987, The Journal of biological chemistry.

[31]  T. H. van der Kwast,et al.  Localization of factor VIII-procoagulant antigen: an immunohistological survey of the human body using monoclonal antibodies. , 1986, Blood.

[32]  R. Schooley,et al.  Cure of hemophilia A by orthotopic liver transplantation. , 1988, Gastroenterology.

[33]  R. McGraw,et al.  Application of molecular genetics to prenatal diagnosis and carrier detection in the hemophilias: some limitations. , 1985, Blood.

[34]  Eric H. Davidson,et al.  Gene activity in early development , 1968 .

[35]  R. Lawn,et al.  Detection of hemophilia A carriers using intragenic factor VIII:C DNA polymorphisms. , 1987 .

[36]  W. Kane,et al.  Blood coagulation factors V and VIII: structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. , 1988, Blood.

[37]  S. Antonarakis,et al.  Nonsense and missense mutations in hemophilia A: estimate of the relative mutation rate at CG dinucleotides. , 1988, American journal of human genetics.

[38]  B. Keyt,et al.  Expression of active human factor VIII from recombinant DNA clones , 1984, Nature.

[39]  T. Griggs,et al.  Purified human factor VIII procoagulant protein: comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[40]  D. Fass,et al.  Porcine factor VIII:C prepared by affinity interaction with von Willebrand factor and heterologous antibodies: sodium dodecyl sulfate polyacrylamide gel analysis. , 1982, Blood.

[41]  J. Katzmann,et al.  Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein. , 1982, Blood.

[42]  J. Roberts,et al.  Localization of human factor FVIII inhibitor epitopes to two polypeptide fragments. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[43]  L. Aledort,et al.  RECOMBINATION BETWEEN FACTOR VIII:C GENE AND St14 LOCUS , 1986, The Lancet.

[44]  D. Barker,et al.  Restriction sites containing CpG show a higher frequency of polymorphism in human DNA , 1984, Cell.

[45]  S. Antonarakis,et al.  Recurrent mutations in haemophilia A give evidence for CpG mutation hotspots , 1986, Nature.

[46]  K. Mullis,et al.  Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. , 1985, Science.

[47]  M. Hultin.  Modulation of thrombin-mediated activation of factor VIII:C by calcium ions, phospholipid, and platelets. , 1985 .